Colorectal cancer

British Medical Journal

Volumn 314, Issue 7098, 1997, Pages 1882-1885

  Dunlop, Malcolm G ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; CANCER SURVIVAL; COLORECTAL CANCER; FAMILIAL CANCER; GENE THERAPY; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; UNITED KINGDOM;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS; GENE THERAPY; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ONCOGENES; PEDIGREE; RISK FACTORS;

EID: 0030912434     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (21)

1. Vasen HFA, Van der Luijt RB, Slors JFM, Buskens E, De Ruiter P, Baeten CGM, et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996;348:433-5.
2. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
3. St John DJB, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ESR. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-90.
4. Dunlop MG. Screening for large bowel neoplasms in individuals with a family history of colorectal cancer. Br J Surg 1992;79:488-94.
5. Jarvinen HJ, Mecklin J-P, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary non-polyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
6. Hacia JG, Brody LC, Chee MS, Fodor SPA, Collins FS. Detection of heterozygous mutations in brca1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nature Genetics 1996;14:441-9.
7. Dunlop MG, Campbell H. Colonoscopic screening for people with a family history of colorectal cancer: a high risk strategy? BMJ (in press.)
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
9. Leach FS, Polyak K, Burrell M, Johnson KA, Hill D, Dunlop MG, et al. Expression of the human mismatch repair gene hmsh2 in normal and neoplastic tissues. Cancer Res 1996;56:235-40.
10. Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele GJ, et al. The dcc protein and prognosis in colorectal cancer. N Engl J Med 1996;335:1727-32.
11. Hayashi N, Ito I, Yanagisawa A, Kato Y, Nakamori S, Imoka S, et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 1995;345:1255-9.
12. Lindeman F, Schlimok G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685-9.
13. Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Xu Qi C, et al. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997;112:1114-20.
14. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-14.
15. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in apc(delta716) knockout mice by inhibition of cyclooxygenase 2 (cox-2). Cell 1996;87:803-9.
16. Korinek V, Barker N, Morin PJ, Van Wichen D, De Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a beta-catenin-tcf complex in apc(-/-) colon carcinoma Science 1997;275:1784-7.
17. Rietmuller G, Schneider Gadicke E, Schlimok G, Schmeigel W, Raab R, Hoffken K, et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected dukes' c colorectal carcinoma. Lancet 1994;343: 1177-83.
18. Huber BE, Richards CA, Austin EA. Vdept: an enzyme/prodrug gene therapy approach for the treatment of metastatic colorectal cancer. Adv Drug Delivery Rev 1995;17:279-92.
19. Da Costa LT, Jen J, He TC, Chan TA, Kinzler KW, Vogelstein B. Converting cancer genes into killer genes. Proc Natl Acad Sci USA 1996;93:4192-6.
20. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 1996;274:373-6.
21. Caruso M, PhamNguyen K, Kwong YL, Xu B, Kosai KI, Finegold M, et al. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA 1996;93:11302-6.